GREENSBORO, N.C. — June is Men’s Health Awareness Month, and doctors are using it to push a message many men may not want to hear but need to take seriously: do not wait until something feels wrong to ...
A new test could make it easier to detect high-risk prostate cancer cases earlier. The blood test, called Stockholm3, is showing promise in clinical trials, beating out the traditional, standard ...
In this blog on Athlon Sports, we will talk about PSA record grading volume June 2026 and its impact. The company achieved its best month ever by grading 2.5 million cards despite freezing its popular ...
Previous research showed that combining the multicomponent blood-based biomarker Stockholm3 test with an MRI-targeted biopsy approach decreased overdetection of prostate cancers, while still detecting ...
A new blood test may make it easier to detect the most dangerous forms of prostate cancer early. In a study from Karolinska Institutet, the Stockholm3 blood test detected more clinically significant ...
A new blood test may make it easier to detect the most dangerous forms of prostate cancer early on. In a study from Karolinska Institutet, the Stockholm3 blood test detected more clinically ...
A new study found the Stockholm3 blood test detected aggressive prostate cancer more accurately than the standard PSA test. Researchers said the test could improve early detection while reducing ...
Morning Overview on MSN
A blood test caught 90% of aggressive prostate cancers, against 74% for the standard PSA
The standard PSA test has anchored prostate cancer screening for decades, but it has a well-known weakness: it flags plenty ...
Morning Overview on MSN
The FDA cleared its first blood test to flag prostate cancer in men with high PSA
An elevated PSA reading has long put men in an uncomfortable position: it signals possible prostate cancer, but it is ...
Patients with advanced prostate cancer may need periodic imaging scans to catch tumor growth even with stable levels of prostate-specific antigen (PSA), a protein in the blood that doctors routinely ...
The net benefit for detecting clinically significant prostate cancer (csPC) is greater with Stockholm3 vs PSA, according to findings from a large prospective study published in th ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results